Substituted spirooxindole derivatives as potent anticancer agents through inhibition of phosphodiesterase 1
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Substituted spirooxindole derivatives as potent anticancer agents through inhibition of phosphodiesterase 1
Authors
Keywords
-
Journal
RSC Advances
Volume 8, Issue 26, Pages 14335-14346
Publisher
Royal Society of Chemistry (RSC)
Online
2018-04-17
DOI
10.1039/c8ra02358a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New spiro-oxindole constructed with pyrrolidine/thioxothiazolidin-4-one derivatives: Regioselective synthesis, X-ray crystal structures, Hirshfeld surface analysis, DFT, docking and antimicrobial studies
- (2018) Assem Barakat et al. JOURNAL OF MOLECULAR STRUCTURE
- Regio- and stereoselective synthesis of new spirooxindoles via 1,3-dipolar cycloaddition reaction: Anticancer and molecular docking studies
- (2018) Gehad Lotfy et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Current Trends towards the Synthesis of Bioactive Heterocycles and Natural Products Using 1,3-Dipolar Cycloadditions (1,3-DC) with Azomethine Ylides
- (2017) H. Döndas et al. SYNTHESIS-STUTTGART
- Spirooxindoles: Promising scaffolds for anticancer agents
- (2015) Bin Yu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008–2014)
- (2015) Alberto Leoni et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Molecular diversity of spirooxindoles. Synthesis and biological activity
- (2015) Tetyana L. Pavlovska et al. MOLECULAR DIVERSITY
- Discovery of a Small Molecule MDM2 Inhibitor (AMG 232) for Treating Cancer
- (2014) Yosup Rew et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances in the synthesis of biologically active spirooxindoles
- (2014) Maria M.M. Santos TETRAHEDRON
- A facile synthesis, anti-inflammatory and analgesic activity of isoxazolyl-2,3-dihydrospiro[benzo[f]isoindole-1,3′-indoline]-2′,4,9-triones
- (2013) E. Rajanarendar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Potent Small-Molecule Inhibitor of the MDM2–p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
- (2013) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diastereomeric Spirooxindoles as Highly Potent and Efficacious MDM2 Inhibitors
- (2013) Yujun Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy
- (2012) Thomas Dexheimer et al. Anti-Cancer Agents in Medicinal Chemistry
- N-Heterocyclic Carbene-Catalyzed Homoenolate Additions with N-Aryl Ketimines as Electrophiles: Efficient Synthesis of Spirocyclic γ-Lactam Oxindoles
- (2012) Bo Zhang et al. CHEMISTRY-A EUROPEAN JOURNAL
- In vitro and in vivo study of cucurbitacins-type triterpene glucoside from Citrullus colocynthis growing in Saudi Arabia against hepatocellular carcinoma
- (2011) Seif-Eldin N. Ayyad et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- FRED Pose Prediction and Virtual Screening Accuracy
- (2011) Mark McGann Journal of Chemical Information and Modeling
- Small molecule agents targeting the p53-MDM2 pathway for cancer therapy
- (2011) Weisi Wang et al. MEDICINAL RESEARCH REVIEWS
- Antimycobacterial activity of spirooxindolo-pyrrolidine, pyrrolizine and pyrrolothiazole hybrids obtained by a three-component regio- and stereoselective 1,3-dipolar cycloaddition
- (2011) Stephen Michael Rajesh et al. MedChemComm
- Substituted spiro [2.3′] oxindolespiro [3.2″]-5,6-dimethoxy-indane-1″-one-pyrrolidine analogue as inhibitors of acetylcholinesterase
- (2010) Mohamed Ashraf Ali et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
- (2010) Paul C. D. Hawkins et al. Journal of Chemical Information and Modeling
- Targeting cancer with phosphodiesterase inhibitors
- (2009) Rajkumar Savai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay
- (2009) C. Marchand et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now